No insider purchase over the last 90 days. The latest, by Li Jing, was filed 13 Jun 2023.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
15 of 15 declarations
Sales weigh on the record of Acotec Scientific Holdings Ltd. - B, a healthcare company listed in Hong Kong with a market capitalisation of HKD 1,798.9 million, of which insiders hold 83.6%. Only three filers appear, for 15 filings in all. The largest transaction is a sale of EUR 41,527,117 by Li Jing, Director, on February 9, 2023, followed by EUR 13,486,398 on June 6, 2023. Schaffner Silvio Rudolf, Director, sold on the same February 9, 2023 for EUR 8,239,462.
Of the 6 sales, 3 carry an amount, for EUR 63,252,977 in total. There are 2 purchases, only one of them with an amount: EUR 547,778, by Li Jing on September 24, 2021. That makes 25% purchases among open-market trades. Seven other filings are of another kind.
Activity is concentrated: 7 filings in 2023, 5 in 2021, one in 2022 and 2 in 2026, and those last 2, the only ones in the last twelve months, are sales. Filings are published a median of 5 days after the trade.
Purchases our model currently ranks for the recommendations list.
All recommendations